Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 7048
Gene Symbol: TGFBR2
TGFBR2
0.070 AlteredExpression disease BEFREE A super-enhancer controls TGF- β signaling in pancreatic cancer through downregulation of TGFBR2. 31730895 2020
Entrez Id: 7048
Gene Symbol: TGFBR2
TGFBR2
0.070 AlteredExpression disease BEFREE Downregulation of TRAIL-Receptor 1 Increases TGFβ Type II Receptor Expression and TGFβ Signalling Via MicroRNA-370-3p in Pancreatic Cancer Cells. 30366420 2018
Entrez Id: 7048
Gene Symbol: TGFBR2
TGFBR2
0.070 GeneticVariation disease BEFREE Treatment of Ptf1a(cre/+) ;LSL-Kras(G12D/+) ;Tgfbr2(flox/flox) mice with the JNK inhibitor decreased growth of murine pancreatic cancer and prolonged survival of the mice significantly. 23237571 2013
Entrez Id: 7048
Gene Symbol: TGFBR2
TGFBR2
0.070 GeneticVariation disease BEFREE Using the whole-cell recording mode of the patch-clamp technique, functional ion channels were electrophysiologically characterized in PANC-1 (K-ras G12D (+/-), p53 R273C, Deltap16), BxPC-3 (smad4-, p53 Y220C, Deltap16), and MiaPaCa-2 [transforming growth factor-beta receptor type II defect, K-ras G12C(-/-), p53 R248W, Deltap16] human pancreatic cancer cell lines. 14978241 2004
Entrez Id: 7048
Gene Symbol: TGFBR2
TGFBR2
0.070 AlteredExpression disease BEFREE Farnesyltransferase inhibitor (L-744,832) restores TGF-beta type II receptor expression and enhances radiation sensitivity in K-ras mutant pancreatic cancer cell line MIA PaCa-2. 12420225 2002
Entrez Id: 7048
Gene Symbol: TGFBR2
TGFBR2
0.070 AlteredExpression disease BEFREE Reversion of transcriptional repression of Sp1 by 5 aza-2' deoxycytidine restores TGF-beta type II receptor expression in the pancreatic cancer cell line MIA PaCa-2. 11507078 2001
Entrez Id: 7048
Gene Symbol: TGFBR2
TGFBR2
0.070 GeneticVariation disease BEFREE Somatic alterations of the TGF-beta type II receptor gene (TGFBR2) were identified in 4 of 97 (4.1%) pancreas cancers, including a homozygous deletion in a replication error-negative cancer and three homozygous frameshift mutations of the poly(A) tract of the TGF-beta type II receptor in replication error-positive cancers. 9850059 1998